Published in Mol Med on August 30, 2006
The triple helix: 50 years later, the outcome. Nucleic Acids Res (2008) 1.73
Potential in vivo roles of nucleic acid triple-helices. RNA Biol (2011) 1.20
Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation. Nucleic Acids Res (2008) 0.96
Polypurine hairpins directed against the template strand of DNA knock down the expression of mammalian genes. J Biol Chem (2009) 0.82
Sequence-specific cleavage of double helical DNA by triple helix formation. Science (1987) 9.20
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature (1995) 8.12
Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res (1988) 4.49
Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[alpha]-thymidylate covalently linked to an azidoproflavine derivative. Nucleic Acids Res (1987) 4.36
Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature (1998) 3.77
Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res (2000) 2.63
Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity (2000) 2.59
Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol (1998) 2.34
Specificity within the ets family of transcription factors. Adv Cancer Res (1998) 2.21
Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J (1997) 2.06
Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. J Clin Invest (1997) 2.04
Specific mutations induced by triplex-forming oligonucleotides in mice. Science (2000) 1.98
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl Acad Sci U S A (1998) 1.93
Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. Circ Res (2001) 1.81
The influence of single base triplet changes on the stability of a pur.pur.pyr triple helix determined by affinity cleaving. Nucleic Acids Res (1992) 1.80
Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J (2000) 1.69
Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. Circ Res (1999) 1.62
Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol (1995) 1.60
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol (2005) 1.57
The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int J Biochem Cell Biol (2001) 1.57
Triplex DNA: fundamentals, advances, and potential applications for gene therapy. J Mol Med (Berl) (1997) 1.54
Triple helix formation and the antigene strategy for sequence-specific control of gene expression. Biochim Biophys Acta (1999) 1.44
Endothelial-specific gene expression directed by the tie gene promoter in vivo. Blood (1995) 1.40
c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol (1992) 1.33
Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc Natl Acad Sci U S A (2000) 1.32
Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J Biol Chem (1998) 1.30
Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res (1994) 1.28
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer (1998) 1.25
Molecular phylogeny of the ETS gene family. Oncogene (1999) 1.24
A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene. J Biol Chem (1996) 1.21
Role of ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter. FASEB J (1999) 1.13
Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest (2001) 1.11
Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res (1994) 1.08
Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation. Nucleic Acids Res (1996) 1.07
Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol (1998) 1.07
Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene. Oncogene (1997) 1.07
The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol (2002) 1.06
Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex. Biochemistry (1998) 1.06
Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol (2001) 1.05
Pax5 (BSAP) regulates the murine immunoglobulin 3' alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription. Proc Natl Acad Sci U S A (1995) 1.02
Current status of antiangiogenic factors. Br J Haematol (2000) 1.01
Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc Natl Acad Sci U S A (1997) 1.00
Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J Biol Chem (2000) 0.99
Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells. Cancer Res (2000) 0.99
Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation. Ann Rheum Dis (2000) 0.96
High-affinity triple helix formation by synthetic oligonucleotides at a site within a selectable mammalian gene. Biochemistry (1995) 0.95
Triplex-forming molecules for modulation of DNA information processing. Curr Opin Mol Ther (2000) 0.95
Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br J Cancer (1996) 0.94
A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells. Biochemistry (1998) 0.93
Characterisation of the tumour necrosis factor (TNF)-(alpha) response elements in the human ICAM-2 promoter. J Cell Sci (1999) 0.91
Triplex targets in the human rhodopsin gene. Biochemistry (1998) 0.87
Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages. Biochemistry (2001) 0.86
The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis. J Mol Med (Berl) (2002) 0.84
Inhibition of interleukin-4- and CD40-induced IgE germline gene promoter activity by 2'-aminoethoxy-modified triplex-forming oligonucleotides. J Biol Chem (2001) 0.83
Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdr1 in MDR cancer cells. FEBS Lett (1994) 0.82
Cloning and partial characterization of the human tie-2 receptor tyrosine kinase gene promoter. Biochem Biophys Res Commun (1998) 0.81
The integral divalent cation within the intermolecular purine*purine. pyrimidine structure: a variable determinant of the potential for and characteristics of the triple helical association. Nucleic Acids Res (1999) 0.80
Ets transcription factor binding site is required for positive and TNF alpha-induced negative promoter regulation. Nucleic Acids Res (1993) 0.78
Modulation of Cm/T, G/A, and G/T triplex stability by conjugate groups in the presence and absence of KCl. Biochemistry (1997) 0.77
Triplex targeting of human PDGF-B (c-sis, proto-oncogene) promoter specifically inhibits factors binding and PDGF-B transcription. Nucleic Acids Res (2001) 0.77
Refinement of the AMBER force field for nucleic acids: improving the description of alpha/gamma conformers. Biophys J (2007) 7.99
Nanomedicine: current status and future prospects. FASEB J (2005) 4.28
A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther (2005) 2.83
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res (2004) 2.52
Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension (2008) 2.42
Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation (2007) 2.35
Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation (2013) 2.34
Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res (2006) 2.12
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09
VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol (2007) 1.61
Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood (2003) 1.49
Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. Thromb Haemost (2014) 1.48
Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res (2006) 1.48
Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res (2002) 1.47
Drug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis. Crit Care Med (2015) 1.45
Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo. Development (2011) 1.44
Biologic effects induced in vitro by PM10 from three different zones of Mexico City. Environ Health Perspect (2002) 1.41
Molecular dynamics simulations of duplex stretching reveal the importance of entropy in determining the biomechanical properties of DNA. Biophys J (2004) 1.35
Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation (2010) 1.32
Mapping the phase diagram of the writhe of DNA nanocircles using atomistic molecular dynamics simulations. Nucleic Acids Res (2007) 1.29
Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications. Oncology (2010) 1.26
Van der Waals interactions dominate ligand-protein association in a protein binding site occluded from solvent water. J Am Chem Soc (2005) 1.24
Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med (2009) 1.24
Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes (2003) 1.20
Strong solute-solute dispersive interactions in a protein-ligand complex. J Am Chem Soc (2005) 1.19
Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology (2009) 1.17
Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res (2005) 1.16
Elucidation of thioredoxin as a molecular target for antitumor quinols. Cancer Res (2005) 1.13
Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res (2013) 1.12
Exploring the counterion atmosphere around DNA: what can be learned from molecular dynamics simulations? Biophys J (2004) 1.11
Is inflammation the cause of pre-eclampsia? Biochem Soc Trans (2011) 1.09
Childhood tuberculosis in household contacts of newly diagnosed TB patients. PLoS One (2012) 1.07
Antitumor benzothiazoles. Frontier molecular orbital analysis predicts bioactivation of 2-(4-aminophenyl)benzothiazoles to reactive intermediates by cytochrome P4501A1. Org Biomol Chem (2003) 1.05
Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors. Int J Cancer (2012) 1.04
Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation (2010) 1.04
The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis. Nat Commun (2012) 1.04
Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide. Circ Res (2009) 1.03
Physical and biomechanical characteristics of rat cervical ripening are not consistent with increased collagenase activity. Am J Obstet Gynecol (2004) 1.02
Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences. PLoS One (2009) 1.02
Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. J Med Chem (2002) 1.01
Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability. PLoS One (2011) 1.00
Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol (2008) 1.00
Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells. Crit Care Med (2007) 0.99
Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates. J Med Chem (2006) 0.99
Theoretical study of large conformational transitions in DNA: the B<-->A conformational change in water and ethanol/water. Nucleic Acids Res (2007) 0.94
LIPOCALIN-2 is a major acute-phase protein in a rat and mouse model of sterile abscess. Shock (2012) 0.92
2-(5-Chloro-1,3-benzothia-zol-2-yl)-4-meth-oxy-phenol. Acta Crystallogr Sect E Struct Rep Online (2012) 0.92
Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia. Hypertension (2010) 0.90
Medical ethics in surgical wards: knowledge, attitude and practice of surgical team members in Karachi. Indian J Med Ethics (2005) 0.89
Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents. J Med Chem (2008) 0.89
Angiopoietin-1 induces migration of monocytes in a tie-2 and integrin-independent manner. Hypertension (2010) 0.89
Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis differently. FEBS Lett (2005) 0.87
VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. Biochem Biophys Res Commun (2006) 0.87
Molecular modelling methods for prediction of sequence-selectivity in DNA recognition. Methods (2007) 0.86
Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain. FEBS J (2006) 0.86
Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells. Hypertension (2010) 0.85
Ferroportin-1 is a 'nuclear'-negative acute-phase protein in rat liver: a comparison with other iron-transport proteins. Lab Invest (2012) 0.85
Active site pressurization: a new tool for structure-guided drug design and other studies of protein flexibility. J Chem Inf Model (2008) 0.84
Long-timescale molecular-dynamics simulations of the major urinary protein provide atomistic interpretations of the unusual thermodynamics of ligand binding. Biophys J (2010) 0.84
Certain imidazotetrazines escape O6-methylguanine-DNA methyltransferase and mismatch repair. Oncology (2011) 0.83
Modulation of trophoblast cell death by oxygen and EGF. Mol Med (2002) 0.83
The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis (2012) 0.82
The release of nitric oxide from S-nitrosothiols promotes angiogenesis. PLoS One (2006) 0.82
Evaluation of molecular modelling methods to predict the sequence-selectivity of DNA minor groove binding ligands. Phys Chem Chem Phys (2009) 0.82
Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1. Eur Heart J (2011) 0.82
Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein. Shock (2013) 0.81
Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers. Org Biomol Chem (2013) 0.81
Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis. Endothelium (2005) 0.81
Molecular dynamics simulations of the adenosine A2a receptor: structural stability, sampling, and convergence. J Chem Inf Model (2013) 0.81
Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent. J Invest Dermatol (2013) 0.81
5-Chloro-2-(3,4,5-trimeth-oxy-phen-yl)-1,3-benzothia-zole. Acta Crystallogr Sect E Struct Rep Online (2012) 0.81
Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta. Am J Obstet Gynecol (2011) 0.81
Rat model of fractionated (2 Gy/day) 60 Gy irradiation of the liver: long-term effects. Radiat Environ Biophys (2013) 0.80
Structural studies on bioactive compounds. Part 36: design, synthesis and biological evaluation of pyrimethamine-based antifolates against Pneumocystis carinii. Bioorg Med Chem (2002) 0.80
Destabilization of DNA duplexes by oxidative damage at guanine: implications for lesion recognition and repair. J R Soc Interface (2008) 0.80
Structure of Mycobacterium tuberculosis thioredoxin in complex with quinol inhibitor PMX464. Protein Sci (2011) 0.79
Down-regulation of angiopoietin-1 expression in menorrhagia. Am J Pathol (2002) 0.79
Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy. Circulation (2011) 0.79
Serum Lipocalin2 is a potential biomarker of liver irradiation damage. Liver Int (2013) 0.78
Force field validation for nucleic acid simulations: comparing energies and dynamics of a DNA dodecamer. J Comput Chem (2005) 0.78
3D QSAR pharmacophore model based on diverse IKKβ inhibitors. J Mol Model (2010) 0.78
The inhibitory effects of vinylphosphonate-linked thymidine dimers on the unidirectional translocation of PcrA helicase along DNA: a molecular modelling study. Phys Chem Chem Phys (2012) 0.78
Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. Int J Cancer (2004) 0.77